3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Leukemia, Biphenotypic, Acute
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Ganglioneuroblastoma
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Recurrence
1
Neuroblastoma
1
Medulloblastoma
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Mast-Cell
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
Graft vs Host Disease
1
GATA2 Deficiency
1
Burkitt Lymphoma
1
Blast Crisis
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
pembrolizumab
15
Cisplatin
7
Cetuximab
5
dostarlimab
3
Surveys and Questionnaires
3
Carboplatin
3
fludarabine
2
abemaciclib
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Nivolumab
2
Interviews as Topic
2
Fulvestrant
2
Docetaxel
2
Cyclophosphamide
2
Blood Specimen Collection
2
130-nm albumin-bound paclitaxel
2
ulixertinib
1
trastuzumab deruxtecan
1
toripalimab
1
tislelizumab
1
ribociclib
1
repotrectinib
1
patritumab deruxtecan
1
palbociclib
1
osimertinib
1
olaparib
1
niraparib
1
nimotuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Thiotepa
×
30 days
×
Clear all
No trials found.